IRIS UniCatt

Marino, Mariapaola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.024
AS - Asia 2.949
EU - Europa 2.224
SA - Sud America 596
AF - Africa 86
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.896
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.877
SG - Singapore 1.419
CN - Cina 648
SE - Svezia 552
BR - Brasile 496
IT - Italia 366
DE - Germania 337
VN - Vietnam 281
FR - Francia 260
IE - Irlanda 129
GB - Regno Unito 127
IN - India 119
JP - Giappone 90
ID - Indonesia 84
UA - Ucraina 78
FI - Finlandia 76
CA - Canada 73
RU - Federazione Russa 72
PL - Polonia 63
HK - Hong Kong 59
MX - Messico 52
BD - Bangladesh 50
AR - Argentina 36
TR - Turchia 31
IQ - Iraq 30
ZA - Sudafrica 30
BE - Belgio 28
NL - Olanda 28
KR - Corea 27
ES - Italia 26
AT - Austria 18
MA - Marocco 16
EC - Ecuador 15
UZ - Uzbekistan 13
CI - Costa d'Avorio 12
CO - Colombia 12
CH - Svizzera 11
PK - Pakistan 11
VE - Venezuela 11
IR - Iran 10
JO - Giordania 10
SA - Arabia Saudita 10
AU - Australia 9
CZ - Repubblica Ceca 9
CL - Cile 8
KE - Kenya 8
BY - Bielorussia 6
LB - Libano 6
LT - Lituania 6
NZ - Nuova Zelanda 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
KZ - Kazakistan 5
MY - Malesia 5
OM - Oman 5
TN - Tunisia 5
BO - Bolivia 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
EG - Egitto 4
HN - Honduras 4
IL - Israele 4
JM - Giamaica 4
NO - Norvegia 4
PH - Filippine 4
PT - Portogallo 4
UY - Uruguay 4
DK - Danimarca 3
GR - Grecia 3
HU - Ungheria 3
KG - Kirghizistan 3
LK - Sri Lanka 3
PE - Perù 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
AZ - Azerbaigian 2
CR - Costa Rica 2
GA - Gabon 2
LV - Lettonia 2
NP - Nepal 2
PA - Panama 2
SV - El Salvador 2
TH - Thailandia 2
TM - Turkmenistan 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
BG - Bulgaria 1
BH - Bahrain 1
BZ - Belize 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
GE - Georgia 1
GY - Guiana 1
IS - Islanda 1
KH - Cambogia 1
LU - Lussemburgo 1
MD - Moldavia 1
Totale 9.889
Salva come PNG Salva come JPEG
Città #
Singapore 844
Chandler 532
Ashburn 510
San Jose 347
New York 153
Beijing 144
Dublin 129
Los Angeles 124
Ho Chi Minh City 97
Rome 94
San Mateo 89
Tokyo 87
The Dalles 84
Dallas 81
Council Bluffs 79
Hefei 77
Jakarta 76
Lauterbourg 72
Hanoi 65
Frankfurt am Main 58
North Bergen 58
Boston 57
Hong Kong 54
Milan 53
Marseille 52
Chicago 51
São Paulo 51
Cattolica 49
Munich 49
Wilmington 49
Princeton 46
Ann Arbor 45
Cambridge 45
Moscow 44
Helsinki 42
Jacksonville 42
Orem 40
Houston 38
Santa Clara 38
Bremen 35
Redwood City 33
Boardman 29
Warsaw 28
Paris 27
Dearborn 26
Woodbridge 26
Montreal 25
Nanjing 25
Atlanta 23
Chennai 23
Hyderabad 23
Seoul 23
Brussels 22
Kent 22
Denver 21
Seattle 20
Buffalo 19
Da Nang 19
Johannesburg 19
Nuremberg 19
Stockholm 19
London 18
Rio de Janeiro 18
Bologna 17
Kraków 17
Toronto 17
Brooklyn 16
Amsterdam 15
Baghdad 15
Falls Church 15
Norwalk 15
San Francisco 15
Lappeenranta 13
Manchester 13
Mexico City 13
Phoenix 13
Querétaro 13
Abidjan 12
Des Moines 12
Dhaka 12
Falkenstein 11
Tashkent 11
Turku 11
Brasília 10
City of London 10
Fairfield 10
Poplar 10
Washington 10
Amman 9
Belo Horizonte 9
Charlotte 9
Düsseldorf 9
Edinburgh 9
Haiphong 9
Lawrence 9
Nanchang 9
Quito 9
Roubaix 9
Shanghai 9
Wroclaw 9
Totale 5.641
Salva come PNG Salva come JPEG
Nome #
Alterazioni delle risposte immuno-infiammatorie nei pazienti affetti da disturbo depressivo maggiore (Immune-inflammatory response changes in patients with major depressive disorder) 268
PTPN22 and myasthenia gravis: replication in an Italian population and meta-analysis of literature data 236
Novel path to IL-6 trans-signaling through thrombin-induced soluble IL-6 receptor release by platelets 221
T cell repertoire in DQ5-positive MuSK-positive myasthenia gravis patients 203
A Study of Inflammatory/Necrosis Biomarkers in the Fracture of the Femur Treated with Proximal Femoral Nail Antirotation 199
Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis 186
Low reliability of anti-KIR4.183-120 peptide auto-antibodies in multiple sclerosis patients 185
Human Leukocyte Antigen Class II associations in late-onset Myasthenia Gravis 176
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis 169
Salivary biomarkers in covid-19 patients: Towards a wide-scale test for monitoring disease activity 168
IL-6 regulates MCP-1, ICAM-1 and IL-6 expression in human myoblasts. 165
Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients 165
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression 163
Myasthenia gravis with antibodies to MuSK: an update 159
Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia 156
HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5. 155
Low reliability of anti-KIR4.183–120peptide auto-antibodies in multiple sclerosis patients 154
Acetylcholine receptor antibody positivity rate in ocular myasthenia gravis: a matter of age? 154
Fluidi ed elettroliti. Equilibrio acido-base 151
Skeletal muscle cells: from local inflammatory response to active immunity 151
Immunological role of IgG subclasses 150
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 146
Cytokines and Hepatocellular Carcinoma: Biomarkers of a Deadly Embrace 145
Circulating and Salivary NGF and BDNF Levels in SARS-CoV-2 Infection: Potential Predictor Biomarkers of COVID-19 Disease-Preliminary Data 141
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities 140
Anti-acetylcholinesterase antibodies associate with ocular myasthenia gravis. 138
Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate 135
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 134
Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins 133
NLRP3 Inflammasome Involvement in Heart, Liver, and Lung Diseases—A Lesson from Cytokine Storm Syndrome 132
Laboratory investigation of hybrid igg4 k/λ in musk positive myasthenia gravis 131
Epidemiological evidence for a hereditary contribution to myasthenia gravis: A retrospective cohort study of patients from North America 130
Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia 127
Immunological role of IgG subclasses 127
Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients 126
Rituximab in myasthenia gravis: a "to be or not to be" inhibitor of T cell function 126
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 125
Serum Neurofilament and Free Light Chain Levels in Patients Undergoing Treatment for Chronic Inflammatory Demyelinating Polyneuropathy 124
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 123
Cryoglobulins: Identification, classification, and novel biomarkers of mysterious proteins 122
Serum Immunoglobulin G (IgG) Subclasses in a Cohort of Systemic Sclerosis Patients 121
Anti-Inflammatory Effects of Curcumin-Based Nanoparticles Containing α-Linolenic Acid in a Model of Psoriasis In Vitro 119
Lack of association between Vitamin D status and free light chains profile with different chronic HCV-related liver and extrahepatic disorders 119
Evaluation of free light chains of immunoglobulins in normal and pathological seminal fluids: Preliminary data 119
The Laboratory Role in anti-TNF Biological Therapy Era 118
Exploratory study of extracellular matrix biomarkers for non-invasive liver fibrosis staging: A machine learning approach with XGBoost and explainable AI 116
Serum immunoglobulin free light chain levels in systemic autoimmune rheumatic diseases 116
A comparative study of serum angiogenic biomarkers in cirrhosis and hepatocellular carcinoma 116
Increased Complement Activation in Systemic Sclerosis Patients with Skin and Lung Fibrosis 115
Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis 106
Anti-MuSK antibodies: Correlation with myasthenia gravis severity 105
Tumor necrosis factor-alpha: ally and enemy in protean cutaneous sceneries 104
Cryoglobulins: putative effectors of adaptive immune response 101
Serum and urine free light chains measurements in patients with systemic sclerosis: novel biomarkers for disease activity 101
Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus 100
IL-6, monocyte infiltration and parenchymal cells 100
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 99
Anti-P110 autoantibodies identify a subtype of "seronegative" myasthenia gravis with prominent oculobulbar involvement 99
Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma 98
The dark side of current analytic methods for Bence Jones Proteinuria 98
Serum levels of free light chains and syndecan-1 in patients with rheumatoid arthritis and systemic lupus erythematosus 95
Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes 95
The Effect of SARS-CoV-2 Vaccination on B-Cell Phenotype in Systemic Sclerosis Patients 92
Type 2 cytokines and scleroderma interstitial lung disease 88
Free light chains and autoimmunity 88
Identification of disease-specific autoantibodies in seronegative myasthenia gravis 87
Immunoglobulin free light chains in severe asthma patient: Could they be a new biomarker? 83
Calprotectin: two sides of the same coin 80
Distinct Biomarker Profiles of B-Cell Activation in Metabolic and Viral Hepatic Fibrosis 80
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis 78
New Biomarkers in Liver Fibrosis: A Pass through the Quicksand? 78
TGF-β1 and IL-10 modulate IL-1β-induced membrane and soluble ICAM-1 in human myoblasts 76
Immune-inflammatory response changes in patients with major depressive disorder 75
A new challenge for urinary free light chains: assessment of the upper reference limit in healthy subjects 74
In Systemic Sclerosis Patients, Peripheral Blood CD21low B Cells and Serum IL-4 and IL-21 Influence Joint Involvement 72
The Evolution of Serological Assays during Two Years of the COVID-19 Pandemic: From an Easy-to-Use Screening Tool for Identifying Current Infections to Laboratory Algorithms for Discovering Immune Protection and Optimizing Vaccine Administration 72
Cryoproteins in Non-HCV-Related Autoimmune Disorders: A Serious Cold-Induced Problem 71
Constitutive and cytokine-induced expression of MHC and intercellular adhesion molecule-1 (ICAM-1) on human myoblasts 68
Anti-adalimumab and anti-certolizumab antibodies titers after discontinuation of adalimumab: Two case reports 67
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis 58
TGF-β1 and IL-10 modulate IL-1β-induced membrane and soluble ICAM-1 in human myoblasts 51
Assessment of Cardiorenal Involvement in Systemic Sclerosis Patients 48
Totale 10.085
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.094
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.094
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202173 0 0 0 0 0 0 0 0 0 6 53 14
2021/2022600 24 15 13 63 56 21 12 98 32 26 103 137
2022/20231.491 223 198 94 236 69 163 84 140 155 28 70 31
2023/2024852 35 180 19 89 33 131 54 35 13 51 91 121
2024/20251.866 75 68 131 66 143 85 51 110 308 157 386 286
2025/20264.444 579 121 324 682 901 227 823 260 250 277 0 0
Totale 10.085